Ravgen
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Ravgen Inc. is a privately owned biotech company founded in 20001 by Chairman and C.E.O. Dr. Ravinder Dhallan. Ravgen Inc. performs research in the prenatal diagnostic field and has developed non-invasive prenatal diagnosis testing for Down Syndrome.
Ravgen Inc. is a privately owned biotech company founded in 2000 by Chairman and C.E.O. Dr. Ravinder Dhallan. Ravgen Inc. performs research in the prenatal diagnostic field and has developed non-invasive prenatal diagnosis testing for Down Syndrome.
Publications and research
Ravgen has published peer-reviewed articles on genetic research in publications such as the Journal of the American Medical Association in 20041, The Lancet in 2007, and the New England Journal of Medicine in 2012. In addition, Ravgen has received some acclaim from its research on non-invasive prenatal DNA testing.
References
External links
Ravgen's official website JAMA (The Journal of the American Medical Association) "Methods to Increase the Percentage of Free Fetal DNA Recovered from the Maternal Circulation" The Lancet "A non-invasive test for prenatal diagnosis based on fetal DNA present in maternal blood: a preliminary study"
Text derived from https://en.wikipedia.org/w/index.php?oldid=1311494783 under CC BY-SA 4.0; modifications have been made.